4-Nitrothalidomide

Intermediate for Pomalidomide. Pomalidomide is a derivative of thalidomide. It is anti-angiogenic and also acts as an immunomodulator. Pomalidomide has been approved on February 28, 2013 by the U.S. Food and Drug Administration (FDA) as a treatment for relapsed and refractory multiple myeloma.

Specifications

Product Name:                  4-Nitrothalidomide

Synonyms:                         N/A

CAS Number:                     19171-18-7

Molecular Weight:            303.2306

Molecular Formula:          C13H9N3O6

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               O=C1CCC(C(=O)N1)N1C(=O)c2c(C1=O)cccc2[N+](=O)[O-]

4-Nitrothalidomide

  • $750.00
  • Ex Tax: $750.00

Available Options